(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 3.91% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.31%.
Caredx's revenue in 2026 is $458,089,000.On average, 9 Wall Street analysts forecast CDNA's revenue for 2026 to be $24,058,483,064, with the lowest CDNA revenue forecast at $23,007,243,653, and the highest CDNA revenue forecast at $24,828,805,644. On average, 9 Wall Street analysts forecast CDNA's revenue for 2027 to be $25,396,847,413, with the lowest CDNA revenue forecast at $21,874,264,169, and the highest CDNA revenue forecast at $27,807,144,863.
In 2028, CDNA is forecast to generate $27,378,785,496 in revenue, with the lowest revenue forecast at $24,036,754,690 and the highest revenue forecast at $29,447,637,074.